349 related articles for article (PubMed ID: 8821512)
21. 4-heterotricyclic substituted 1,4-dihydropyridines with a potent selective bradycardic effect.
Rampa A; Chiarini A; Bisi A; Budriesi R; Valenti P
Arzneimittelforschung; 1991 Jul; 41(7):705-9. PubMed ID: 1772458
[TBL] [Abstract][Full Text] [Related]
22. [35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties.
Knaus HG; Striessnig J; Hering S; Marrer S; Schwenner E; Höltje HD; Glossmann H
Mol Pharmacol; 1992 Feb; 41(2):298-307. PubMed ID: 1311409
[TBL] [Abstract][Full Text] [Related]
23. Evidence for the presence of regional differences in the calcium antagonist receptors in lower urinary tract smooth muscle.
Latifpour J; Yoshida M; Weiss RM
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jun; 345(6):679-87. PubMed ID: 1386146
[TBL] [Abstract][Full Text] [Related]
24. Effect of inorganic calcium channel blockers on dihydropyridine binding to cardiac sarcolemma.
Schilling WP; Zaher MC; Rampe D
Mol Pharmacol; 1990 Jan; 37(1):80-9. PubMed ID: 2137194
[TBL] [Abstract][Full Text] [Related]
25. Vascular and myocardial effects of amlodipine: an overview.
Nayler WG; Gu XH
Postgrad Med J; 1991; 67 Suppl 5():S41-3. PubMed ID: 1839439
[TBL] [Abstract][Full Text] [Related]
26. NZ-105, a new 1,4-dihydropyridine derivative: correlation between dihydropyridine receptor binding and inhibition of calcium uptake in rabbit aorta.
Yamashita T; Masuda Y; Sakai T; Tanaka S; Kasuya Y
Jpn J Pharmacol; 1991 Nov; 57(3):337-48. PubMed ID: 1667534
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and cardiovascular properties of furazanyl-1,4-dihydropyridines and of furoxanyl analogues.
Gasco AM; Fruttero R; Sorba G; Gasco A; Budriesi R; Chiarini A
Arzneimittelforschung; 1992 Jul; 42(7):921-5. PubMed ID: 1418057
[TBL] [Abstract][Full Text] [Related]
28. (+)-S-12967 and (-)-S-12968: 1,4-dihydropyridine stereoisomers with calcium channel agonistic and antagonistic properties in rat resistance arteries.
Prieto D; Mulvany MJ; Nyborg NC
Br J Pharmacol; 1991 Jul; 103(3):1703-8. PubMed ID: 1933134
[TBL] [Abstract][Full Text] [Related]
29. Long-acting dihydropyridine calcium antagonists. 4. Synthesis and structure-activity relationships for a series of basic and nonbasic derivatives of 2-[(2-aminoethoxy)methyl]-1,4-dihydropyridine calcium antagonists.
Alker D; Campbell SF; Cross PE; Burges RA; Carter AJ; Gardiner DG
J Med Chem; 1990 Feb; 33(2):585-91. PubMed ID: 2153819
[TBL] [Abstract][Full Text] [Related]
30. [Effects of benzyltetrahydropalmatine on rat portal vein and guinea pig myocardium].
Xia GJ; Yao WX; Song D; Jiang MX
Zhongguo Yao Li Xue Bao; 1992 May; 13(3):271-3. PubMed ID: 1442113
[TBL] [Abstract][Full Text] [Related]
31. The effects of strychnine on the regulation of voltage-dependent calcium channels by dihydropyridines in brain and heart.
O'Neill SK; Bolger GT
Pharmacol Biochem Behav; 1990 Apr; 35(4):833-40. PubMed ID: 1693213
[TBL] [Abstract][Full Text] [Related]
32. The unique binding properties of amlodipine: a long-acting calcium antagonist.
Nayler WG; Gu XH
J Hum Hypertens; 1991 Aug; 5 Suppl 1():55-9. PubMed ID: 1834847
[TBL] [Abstract][Full Text] [Related]
33. The pharmacological profile of amlodipine in relation to ischaemic heart disease.
Burges RA
Postgrad Med J; 1991; 67 Suppl 3():S9-15. PubMed ID: 1836872
[TBL] [Abstract][Full Text] [Related]
34. Influence of age on norepinephrine-induced vascular contractions as a function of extracellular calcium.
Carrier GO; Jackson CV; Owen MP
Res Commun Chem Pathol Pharmacol; 1979 Dec; 26(3):433-46. PubMed ID: 523780
[TBL] [Abstract][Full Text] [Related]
35. Comparison of aortic calcium and contractility in male, female and lactating female rats.
DeFelice AF; Joiner PD
J Pharmacol Exp Ther; 1975 Jul; 194(1):191-204. PubMed ID: 1151750
[TBL] [Abstract][Full Text] [Related]
36. A sustained occupancy in vivo of cardiovascular calcium antagonist receptors by mepirodipine and its relation to pharmacodynamic effect in spontaneously hypertensive rats.
Yamada S; Matsuoka Y; Kato Y; Kimura R; Inagaki O
J Pharmacol Exp Ther; 1992 Aug; 262(2):589-94. PubMed ID: 1323654
[TBL] [Abstract][Full Text] [Related]
37. Antihypertensive effect of the new dihydropyridine calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl methyl 4-(2-fluoro-5-nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedica rbo xylate hydrochloride in dogs.
Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
Arzneimittelforschung; 1992 Apr; 42(4):513-8. PubMed ID: 1642675
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of some 1,4-dihydropyridine derivatives and their calcium antagonistic activity.
Safak C; Sahin I; Sunal R
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):119-22. PubMed ID: 2334450
[TBL] [Abstract][Full Text] [Related]
39. Negative inotropic and chronotropic activity of calcium channel ligands possessing a xanthone 1,4-dihydropyridine backbone.
Chiarini A; Rampa A; Bisi A; Budriesi R; Valenti P
Arzneimittelforschung; 1992 Jun; 42(6):797-801. PubMed ID: 1329778
[TBL] [Abstract][Full Text] [Related]
40. [New findings on calcium antagonism].
Ferrari R; Ceconi C; Curello S; Visioli O
Ann Ital Med Int; 1992; 7(3 Suppl):100S-111S. PubMed ID: 1338419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
